JP2013521288A5 - - Google Patents

Download PDF

Info

Publication number
JP2013521288A5
JP2013521288A5 JP2012556126A JP2012556126A JP2013521288A5 JP 2013521288 A5 JP2013521288 A5 JP 2013521288A5 JP 2012556126 A JP2012556126 A JP 2012556126A JP 2012556126 A JP2012556126 A JP 2012556126A JP 2013521288 A5 JP2013521288 A5 JP 2013521288A5
Authority
JP
Japan
Prior art keywords
hydroxy
aryl
alkyl
heterocyclyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012556126A
Other languages
English (en)
Japanese (ja)
Other versions
JP5937971B2 (ja
JP2013521288A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/026424 external-priority patent/WO2011109267A1/en
Publication of JP2013521288A publication Critical patent/JP2013521288A/ja
Publication of JP2013521288A5 publication Critical patent/JP2013521288A5/ja
Application granted granted Critical
Publication of JP5937971B2 publication Critical patent/JP5937971B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012556126A 2010-03-04 2011-02-28 カテコールo−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用 Expired - Fee Related JP5937971B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31038610P 2010-03-04 2010-03-04
US61/310,386 2010-03-04
PCT/US2011/026424 WO2011109267A1 (en) 2010-03-04 2011-02-28 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders

Publications (3)

Publication Number Publication Date
JP2013521288A JP2013521288A (ja) 2013-06-10
JP2013521288A5 true JP2013521288A5 (https=) 2014-04-17
JP5937971B2 JP5937971B2 (ja) 2016-06-22

Family

ID=44542514

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012556126A Expired - Fee Related JP5937971B2 (ja) 2010-03-04 2011-02-28 カテコールo−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用

Country Status (17)

Country Link
US (1) US8969364B2 (https=)
EP (1) EP2542084B1 (https=)
JP (1) JP5937971B2 (https=)
KR (1) KR101761963B1 (https=)
CN (1) CN102858177B (https=)
AU (1) AU2011223888B2 (https=)
BR (1) BR112012021656A2 (https=)
CA (1) CA2789475C (https=)
DK (1) DK2542084T3 (https=)
ES (1) ES2662332T3 (https=)
HU (1) HUE036431T2 (https=)
MX (1) MX336711B (https=)
NO (1) NO2542084T3 (https=)
PL (1) PL2542084T3 (https=)
PT (1) PT2542084T (https=)
RU (1) RU2572624C2 (https=)
WO (1) WO2011109267A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
AU2012337781B2 (en) 2011-11-15 2017-07-06 Takeda Pharmaceutical Company Limited Dihydroxy aromatic heterocyclic compound
TWI638802B (zh) 2012-05-24 2018-10-21 芬蘭商奧利安公司 兒茶酚o-甲基轉移酶活性抑制化合物
BR112014030284B1 (pt) 2012-07-18 2021-11-30 Sunshine Lake Pharma Co., Ltd Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
WO2014043252A2 (en) * 2012-09-11 2014-03-20 Rutgers, The State University Of New Jersey Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
KR101685862B1 (ko) 2012-12-27 2016-12-20 에프. 호프만-라 로슈 아게 Comt 억제제
DK3013813T3 (da) 2013-06-27 2019-06-03 Pfizer Heteroaromatiske forbindelser og anvendelse deraf som dopamin-d1-ligander
US9902712B2 (en) 2013-12-19 2018-02-27 Sunshine Lake Pharma Co., Ltd. Nitrogenous heterocyclic derivatives and their application in drugs
PL236355B1 (pl) 2015-04-02 2021-01-11 Celon Pharma Spolka Akcyjna Pochodne 7-(morfolin-4-ylo)pirazolo[1,5-α]pirymidyny jako inhibitory kinazy PI3
EP3733188B1 (en) * 2015-06-08 2023-01-25 The Regents of the University of California Use of h3k9me3 modulation for enhancing cognitive function
AU2019395201A1 (en) 2018-12-06 2021-05-20 Daiichi Sankyo Company, Limited Cycloalkane-1,3-diamine derivative
CN113499525A (zh) * 2021-08-25 2021-10-15 骆艳 一种针对发展性阅读障碍儿童的训练系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3631045A (en) * 1969-11-04 1971-12-28 American Home Prod 4 5-diamino-7h-pyrrolo(2 3-d)pyrimidine derivatives
US3910913A (en) * 1969-11-04 1975-10-07 American Home Prod 4,5-Diamino-7H-pyrrolo{8 2,3-d{9 pyrimidine derivatives
DOP1981004033A (es) * 1980-12-23 1990-12-29 Ciba Geigy Ag Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
US5726124A (en) * 1992-07-17 1998-03-10 Rohm And Haas Company 2-arylpyrimidines and herbicidal use thereof
CA2416248A1 (en) 2000-07-18 2002-01-24 Neurogen Corporation 5-substituted 2-aryl-4-pyrimidinones
SE0004053D0 (sv) * 2000-11-06 2000-11-06 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
IL161337A0 (en) * 2001-10-26 2004-09-27 Angeletti P Ist Richerche Bio N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
RU2004135554A (ru) * 2002-05-09 2006-01-20 Цитокинетикс, Инк. (Us) Пиримидиноны, композиции на их основе и способы их использования
US6930117B2 (en) 2002-11-09 2005-08-16 The Procter & Gamble Company N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
US8455489B2 (en) * 2003-11-10 2013-06-04 Exelixis, Inc. Substituted pyrimidine compositions and methods of use
TW200526635A (en) * 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
GB0515327D0 (en) * 2005-07-26 2005-08-31 Portela & Ca Sa Comt inhibitors
JP2009007273A (ja) * 2007-06-27 2009-01-15 Ajinomoto Co Inc ジアミノピリミジン化合物の製造方法
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
JP5442852B2 (ja) * 2009-08-13 2014-03-12 田辺三菱製薬株式会社 タウプロテインキナーゼ1阻害剤としてのピリミドン誘導体
US9328075B2 (en) * 2011-05-05 2016-05-03 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for treating influenza

Similar Documents

Publication Publication Date Title
JP2013521288A5 (https=)
RU2012142171A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение в лечении психических расстройств
JP2013521286A5 (https=)
JP2012521428A5 (https=)
RU2012142180A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение для лечения психотических расстройств
JP2013521285A5 (https=)
JP2012521429A5 (https=)
JP2015503507A5 (https=)
RU2012142194A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение при лечении психотических расстройств
JP2014526500A5 (https=)
JP2016164184A5 (https=)
JP2019512535A5 (https=)
JP2010523556A5 (https=)
RU2008134423A (ru) Новые производные пиридина
JP2017537960A5 (https=)
JP2016538313A5 (https=)
JP2012525431A5 (https=)
RU2015139590A (ru) ИНГИБИРУЮЩЕЕ Trk СОЕДИНЕНИЕ
MX2007014377A (es) Inhibidores de proteina cinasa de derivados de pirrol (2,3-b) piridina.
JP2016516699A5 (https=)
JP2016525075A5 (https=)
JP2020516671A5 (https=)
JP2013519724A5 (https=)
JP2011528658A5 (https=)
JP2014505107A5 (https=)